Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
EV/EBIT

    Back to All Ratios
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year EV/EBIT History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   EV/EBIT(x) 38.870.260.94-0.11

What is the latest EV/EBIT ratio of CORONA REMEDIES ?

The latest EV/EBIT ratio of CORONA REMEDIES is 38.87 based on Mar2026 Consolidated results.
Year EV/EBIT
Mar202638.87
Mar20250.26
Mar20240.94
Mar2023-0.11

How is EV/EBIT of CORONA REMEDIES Trending?

Years EV/EBIT % Change
Mar2026 38.87
14,850.00
Mar2025 0.26
-72.34
Mar2024 0.94
Positive
Mar2023 -0.11 -

Other Financial Ratios of CORONA REMEDIES


Compare EV/EBIT ratio of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,326.6 Cr -1.2% -8% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,067.0 Cr -2.3% -5.9% 6.2% Stock Analytics
DIVIS LABORATORIES ₹248,983.0 Cr -1.7% -1.1% 60.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,974.0 Cr -2.1% -5.1% 32.2% Stock Analytics
CIPLA ₹106,130.0 Cr -2.2% -4% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹102,707.0 Cr 1.8% 7.6% -4.3% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-1.2%

-8%

NA
SENSEX

-0.6%

-4.8%

-11.4%


You may also like the below Video Courses